Oxygen distribution in murine tumors: characterization using oxygen-dependent quenching of phosphorescence
Open Access
- 1 April 2005
- journal article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 98 (4) , 1503-1510
- https://doi.org/10.1152/japplphysiol.01140.2004
Abstract
In the present work, a novel method for detecting hypoxia in tumors, phosphorescence quenching, was used to evaluate tissue and tumor oxygenation. This technique is based on the concept that phosphorescence lifetime and intensity are inversely proportional to the oxygen concentration in the tissue sample. We used the phosphor Oxyphor G2 to evaluate the oxygen profiles in three murine tumor models: K1735 malignant melanoma, RENCA renal cell carcinoma, and Lewis lung carcinoma. Oxygen measurements were obtained both as histograms of oxygen distribution within the sample and as an average oxygen pressure within the tissue sampled; the latter allowing real-time oxygen monitoring. Each of the tumor types examined had a characteristic and consistent oxygen profile. K1735 tumors were all well oxygenated, with a peak oxygen pressure of 37.8 ± 5.1 Torr; RENCA tumors had intermediate oxygen pressures, with a peak oxygen pressure of 24.8 ± 17.9 Torr; and LLC tumors were all severely hypoxic, with a peak oxygen pressure of 1.8 ± 1.1 Torr. These results correlated well with measurements of tumor cell oxygenation measured by nitroimidazole (EF5) binding and were consistent with assessments of tumor blood flow by contrast enhanced ultrasound and tumor histology. The results show that phosphorescence quenching is a reliable, reproducible, and noninvasive method capable of providing real-time determination of oxygen concentrations within tumors.Keywords
This publication has 42 references indexed in Scilit:
- Comparative Measurements of Hypoxia in Human Brain Tumors Using Needle Electrodes and EF5 BindingCancer Research, 2004
- Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markersRadiotherapy and Oncology, 2003
- Tissue oxygen tension during regional low-flow perfusion in neonatesThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Oxyphor R2 and G2: phosphors for measuring oxygen by oxygen-dependent quenching of phosphorescenceAnalytical Biochemistry, 2002
- Hypoxic Heterogeneity in Human TumorsAmerican Journal of Clinical Oncology, 2001
- In vivo monitoring of tumor angiogenesis with MR imagingAcademic Radiology, 2000
- Evaluation of tumor angiogenesis with US: Imaging, Doppler, and contrast agentsAcademic Radiology, 2000
- Angiogenesis in cancer and other diseasesNature, 2000
- Vascular Permeability Factor/Vascular Endothelial Growth Factor and the Significance of Microvascular Hyperpermeability in AngiogenesisPublished by Springer Nature ,1999
- Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neckInternational Journal of Radiation Oncology*Biology*Physics, 1997